Michaela Nygårdas

486 total citations
14 papers, 255 citations indexed

About

Michaela Nygårdas is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Michaela Nygårdas has authored 14 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Michaela Nygårdas's work include Herpesvirus Infections and Treatments (10 papers), Virus-based gene therapy research (7 papers) and RNA Interference and Gene Delivery (3 papers). Michaela Nygårdas is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), Virus-based gene therapy research (7 papers) and RNA Interference and Gene Delivery (3 papers). Michaela Nygårdas collaborates with scholars based in Finland, Italy and Germany. Michaela Nygårdas's co-authors include Veijo Hukkanen, Henrik Paavilainen, Dennis H. Bamford, Minna M. Poranen, Eeva Broberg, Matias Röyttä, A. Salmi, Tero Vahlberg, Beate Sodeik and Claus‐Henning Nagel and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Michaela Nygårdas

14 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Nygårdas Finland 11 141 106 84 67 28 14 255
Henrik Paavilainen Finland 13 164 1.2× 137 1.3× 108 1.3× 82 1.2× 36 1.3× 19 298
Amanda G. Blouin United States 9 94 0.7× 72 0.7× 133 1.6× 50 0.7× 10 0.4× 15 299
Lucile G. M. Guion United States 7 193 1.4× 118 1.1× 112 1.3× 101 1.5× 30 1.1× 8 317
Brian Schultz United States 4 183 1.3× 206 1.9× 130 1.5× 104 1.6× 62 2.2× 6 398
Nurith Mador Israel 11 216 1.5× 100 0.9× 73 0.9× 118 1.8× 26 0.9× 17 358
Matthew T. Sacco United States 7 67 0.5× 195 1.8× 43 0.5× 76 1.1× 47 1.7× 7 298
Neha J. Pancholi United States 7 88 0.6× 197 1.9× 125 1.5× 67 1.0× 38 1.4× 7 341
Céline Van den Broeke Belgium 13 281 2.0× 151 1.4× 69 0.8× 137 2.0× 52 1.9× 16 524
Christina Öhrmalm Sweden 9 64 0.5× 307 2.9× 87 1.0× 47 0.7× 49 1.8× 12 420
Andy Chan Hong Kong 9 84 0.6× 114 1.1× 57 0.7× 34 0.5× 59 2.1× 13 281

Countries citing papers authored by Michaela Nygårdas

Since Specialization
Citations

This map shows the geographic impact of Michaela Nygårdas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Nygårdas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Nygårdas more than expected).

Fields of papers citing papers by Michaela Nygårdas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Nygårdas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Nygårdas. The network helps show where Michaela Nygårdas may publish in the future.

Co-authorship network of co-authors of Michaela Nygårdas

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Nygårdas. A scholar is included among the top collaborators of Michaela Nygårdas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Nygårdas. Michaela Nygårdas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pennisi, Rosamaria, et al.. (2017). The ERK-1 function is required for HSV-1-mediated G1/S progression in HEP-2 cells and contributes to virus growth. Scientific Reports. 7(1). 9176–9176. 19 indexed citations
2.
Nygårdas, Michaela, et al.. (2016). Interleukin-27 Inhibits Herpes Simplex Virus Type 1 Infection by Activating STAT1 and 3, Interleukin-6, and Chemokines IP-10 and MIG. Journal of Interferon & Cytokine Research. 36(11). 617–629. 15 indexed citations
3.
Paavilainen, Henrik, et al.. (2016). Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools. Journal of Medical Virology. 88(12). 2196–2205. 21 indexed citations
4.
Paavilainen, Henrik, et al.. (2016). Topical Treatment of Herpes Simplex virus Infection with Enzymatically Created siRNA Swarm. Antiviral Therapy. 22(7). 631–637. 22 indexed citations
5.
Hukkanen, Veijo, et al.. (2014). The combined effects of irradiation and herpes simplex virus type 1 infection on an immortal gingival cell line. Virology Journal. 11(1). 125–125. 10 indexed citations
6.
Paavilainen, Henrik, et al.. (2014). Innate responses to small interfering RNA pools inhibiting herpes simplex virus infection in astrocytoid and epithelial cells. Innate Immunity. 21(4). 349–357. 16 indexed citations
7.
Nygårdas, Michaela, Henrik Paavilainen, Claus‐Henning Nagel, et al.. (2013). A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity. PLoS ONE. 8(5). e64200–e64200. 27 indexed citations
8.
Hukkanen, Veijo & Michaela Nygårdas. (2013). The Virtues and Vices of Harnessing HSV Vectors for CNS Autoimmunity Modulation. Immunotherapy. 5(9). 911–913. 1 indexed citations
9.
10.
Nygårdas, Michaela, et al.. (2011). Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5. Gene Therapy. 18(7). 646–655. 21 indexed citations
11.
Nygårdas, Michaela, Tytti Vuorinen, Antti Aalto, Dennis H. Bamford, & Veijo Hukkanen. (2009). Inhibition of coxsackievirus B3 and related enteroviruses by antiviral short interfering RNA pools produced using φ6 RNA-dependent RNA polymerase. Journal of General Virology. 90(10). 2468–2473. 15 indexed citations
12.
Broberg, Eeva, et al.. (2006). Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy. International Immunopharmacology. 6(5). 817–829. 4 indexed citations
13.
Broberg, Eeva, et al.. (2004). Spread and Replication of and Immune Response to γ 1 34.5-Negative Herpes Simplex Virus Type 1 Vectors in BALB/c Mice. Journal of Virology. 78(23). 13139–13152. 23 indexed citations
14.
Broberg, Eeva, Michaela Nygårdas, A. Salmi, & Veijo Hukkanen. (2003). Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by Light Cycler quantitative real-time PCR. Journal of Virological Methods. 112(1-2). 53–65. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrik Paavilainen Breakdown of academic impact, for papers by Amanda G. Blouin Breakdown of academic impact, for papers by Lucile G. M. Guion Breakdown of academic impact, for papers by Brian Schultz Breakdown of academic impact, for papers by Nurith Mador Breakdown of academic impact, for papers by Matthew T. Sacco Breakdown of academic impact, for papers by Neha J. Pancholi Breakdown of academic impact, for papers by Céline Van den Broeke Breakdown of academic impact, for papers by Christina Öhrmalm Breakdown of academic impact, for papers by Andy Chan
Rankless by CCL
2026